ONC offers guidance on EHR contract terms

The Office of the National Coordinator for Health IT (ONC) has issued guidance that explains important contract terms when negotiating with a vendor to purchase an EHR product in an effort to better help organizations select the most appropriate EHR.

Research firm Westat prepared the guidance under a contract with ONC. Understanding the terms can help organizations make the best choices, protect them from business and safety risks, and ensure the EHR and vendor do what is expected, according to the guidance. “If you misunderstand these terms, you may not be able to rely on your contract to help prevent disruptions to your practice.”

Most EHR vendors offer standardized contracts with some negotiable terms; others won’t change any terms, the guidance notes. “If you decide to accept standard EHR technology developer contract terms without negotiation, it may be especially important to understand the implications of the standard terms and to make yourself aware of terms that may not be in the contract that could provide you with added legal protection.”

The terms covered in the guidance, what they mean and what providers need to know about them, are: Indemnification and Hold Harmless, Confidentiality and Non-disclosure Agreements, Warranties and Disclaimers, Limitation of Liability, Dispute Resolution, Termination and Wind Down and Intellectual Property Disputes.

The guidance is available here.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.